Business Wire
BusinessLilly shares early Phase 1 findings for FRα-targeting antibody-drug conjugate in platinum-sensitive ovarian cancer at ESMO 2026The Apex TimesBusinessChina’s incremental market-access move reignites attention on global payment networks like MastercardThe Apex TimesBusinessLockheed Martin’s lower valuation versus RTX draws investor comparison, as defense spending remains a key tailwindThe Apex TimesBusinessOpinion piece pits Nvidia against TSMC for a single, five-year AI betThe Apex TimesBusinessNike approves Genon AI system to automate outsole defect checks, rollout planned for 2027The Apex TimesBusinessBroadcom options market shows outsized appetite for a $600-call bet as “AI fears” enter the debateThe Apex TimesBusinessAmazon buys 3M products for data centers, a move analysts say could ripple across the marketThe Apex TimesBusinessBooz Allen Hamilton shares catch a bid after earnings beat and higher full-year adjusted outlookThe Apex TimesBusinessPalantir expands “sovereign AI” push, betting that controlled deployment wins enterprise and government buyersThe Apex TimesBusinessNVIDIA chief Jensen Huang counters the memory-bear narrative as investors rush to reprice AI hardware timelinesThe Apex TimesBusinessElon Musk argues Tesla’s customer demand is driven by Full Self-Driving, not car-by-car specsThe Apex TimesBusinessCostco starts selling an AI smartphone gimbal on member-only shelves, indicating a new push into camera techThe Apex TimesBusinessLilly shares early Phase 1 findings for FRα-targeting antibody-drug conjugate in platinum-sensitive ovarian cancer at ESMO 2026The Apex TimesBusinessChina’s incremental market-access move reignites attention on global payment networks like MastercardThe Apex TimesBusinessLockheed Martin’s lower valuation versus RTX draws investor comparison, as defense spending remains a key tailwindThe Apex TimesBusinessOpinion piece pits Nvidia against TSMC for a single, five-year AI betThe Apex TimesBusinessNike approves Genon AI system to automate outsole defect checks, rollout planned for 2027The Apex TimesBusinessBroadcom options market shows outsized appetite for a $600-call bet as “AI fears” enter the debateThe Apex TimesBusinessAmazon buys 3M products for data centers, a move analysts say could ripple across the marketThe Apex TimesBusinessBooz Allen Hamilton shares catch a bid after earnings beat and higher full-year adjusted outlookThe Apex TimesBusinessPalantir expands “sovereign AI” push, betting that controlled deployment wins enterprise and government buyersThe Apex TimesBusinessNVIDIA chief Jensen Huang counters the memory-bear narrative as investors rush to reprice AI hardware timelinesThe Apex TimesBusinessElon Musk argues Tesla’s customer demand is driven by Full Self-Driving, not car-by-car specsThe Apex TimesBusinessCostco starts selling an AI smartphone gimbal on member-only shelves, indicating a new push into camera techThe Apex TimesBusinessLilly shares early Phase 1 findings for FRα-targeting antibody-drug conjugate in platinum-sensitive ovarian cancer at ESMO 2026The Apex TimesBusinessChina’s incremental market-access move reignites attention on global payment networks like MastercardThe Apex TimesBusinessLockheed Martin’s lower valuation versus RTX draws investor comparison, as defense spending remains a key tailwindThe Apex TimesBusinessOpinion piece pits Nvidia against TSMC for a single, five-year AI betThe Apex TimesBusinessNike approves Genon AI system to automate outsole defect checks, rollout planned for 2027The Apex TimesBusinessBroadcom options market shows outsized appetite for a $600-call bet as “AI fears” enter the debateThe Apex TimesBusinessAmazon buys 3M products for data centers, a move analysts say could ripple across the marketThe Apex TimesBusinessBooz Allen Hamilton shares catch a bid after earnings beat and higher full-year adjusted outlookThe Apex TimesBusinessPalantir expands “sovereign AI” push, betting that controlled deployment wins enterprise and government buyersThe Apex TimesBusinessNVIDIA chief Jensen Huang counters the memory-bear narrative as investors rush to reprice AI hardware timelinesThe Apex TimesBusinessElon Musk argues Tesla’s customer demand is driven by Full Self-Driving, not car-by-car specsThe Apex TimesBusinessCostco starts selling an AI smartphone gimbal on member-only shelves, indicating a new push into camera techThe Apex TimesBusinessLilly shares early Phase 1 findings for FRα-targeting antibody-drug conjugate in platinum-sensitive ovarian cancer at ESMO 2026The Apex TimesBusinessChina’s incremental market-access move reignites attention on global payment networks like MastercardThe Apex TimesBusinessLockheed Martin’s lower valuation versus RTX draws investor comparison, as defense spending remains a key tailwindThe Apex TimesBusinessOpinion piece pits Nvidia against TSMC for a single, five-year AI betThe Apex TimesBusinessNike approves Genon AI system to automate outsole defect checks, rollout planned for 2027The Apex TimesBusinessBroadcom options market shows outsized appetite for a $600-call bet as “AI fears” enter the debateThe Apex TimesBusinessAmazon buys 3M products for data centers, a move analysts say could ripple across the marketThe Apex TimesBusinessBooz Allen Hamilton shares catch a bid after earnings beat and higher full-year adjusted outlookThe Apex TimesBusinessPalantir expands “sovereign AI” push, betting that controlled deployment wins enterprise and government buyersThe Apex TimesBusinessNVIDIA chief Jensen Huang counters the memory-bear narrative as investors rush to reprice AI hardware timelinesThe Apex TimesBusinessElon Musk argues Tesla’s customer demand is driven by Full Self-Driving, not car-by-car specsThe Apex TimesBusinessCostco starts selling an AI smartphone gimbal on member-only shelves, indicating a new push into camera techThe Apex Times
Back to front
Netflix announces “Ad Vitam Eternam,” a sequel to its 2025 film “Ad Vitam”
The Apex Times

THE APEX TIMES

Business/The Apex Times/Aug 10, 3:25 PM EDT

Netflix announces “Ad Vitam Eternam,” a sequel to its 2025 film “Ad Vitam”

Netflix said it is developing a sequel to the 2025 title “Ad Vitam,” starring Guillaume Canet, and framed the move as another push to broaden its original film slate.

Netflix has announced it is moving forward with a sequel to its 2025 film “Ad Vitam,” naming the follow-up “Ad Vitam Eternam.” The announcement was published in Netflix’s Newsroom on Aug. 10, 2026, positioning the new project as a continuation of a story it previously brought to the platform through its original film strategy.

According to Netflix’s release, “Ad Vitam” starred Guillaume Canet, and the new entry in the franchise, “Ad Vitam Eternam,” is presented as a sequel to that earlier film. Beyond the announcement of the title and its link to the earlier movie, Netflix did not provide additional deal terms or production timeline details in the information available here.

Netflix did not outline casting beyond the connection to Canet, nor did it specify a release window, director, or format in the announcement details provided for this review. In that same way, Netflix did not describe whether the sequel will follow the same creative team or production structure used for “Ad Vitam.”

The move fits into a broader pattern in streaming entertainment where platforms lean on recognizable properties, including sequels and established franchises, to stabilize audience demand in a crowded market. Original films remain a key differentiator for streaming services, especially as studios and distributors compete for subscriber attention with both licensed titles and in-house productions.

Netflix has increasingly positioned its global slate to reflect regional storytelling as well as international appeal, a model that has helped it broaden reach beyond the U.S. market. European talent and storylines, when successful, can also travel well internationally, making follow-on projects attractive when the first installment generates enough viewership and buzz to justify the next chapter.

Even with Netflix’s announcement, some of the operational questions that typically accompany sequel development were not answered in the available announcement text. For example, it was not disclosed here how Netflix is structuring the financing, whether it is partnering with the same production companies as the first film, or how the company expects to handle marketing and distribution for the sequel.

What to watch next is whether Netflix will publish additional details, such as the creative team attached to “Ad Vitam Eternam,” supporting cast confirmations, start-of-production timing, and any target release period. Those elements will determine how quickly the sequel can move from announcement to audience, and whether the project is likely to become a major scheduling anchor for the company’s film calendar.

For now, Netflix’s statement mostly establishes that it is betting on continuation of a specific film property and indicating that franchise development remains part of its original content roadmap. Additional disclosures, if and when they come, will clarify the scale of the project and its priority relative to other upcoming releases.

Why It Matters

  • Sequels can help streaming services reduce uncertainty by leaning on prior audience awareness rather than building demand from scratch.
  • Netflix’s choice to continue “Ad Vitam” indicates continued investment in original films and franchise-style IP development.
  • The next set of disclosures on cast and production schedules will indicate how aggressively Netflix plans to roll out new film content.

Sources

Key Facts

  • Netflix announced it is developing “Ad Vitam Eternam,” a sequel to its 2025 film “Ad Vitam.”
  • The original “Ad Vitam” starred Guillaume Canet, and Netflix linked the sequel to the earlier film.
  • The announcement was published in Netflix’s Newsroom on Aug. 10, 2026.
  • In the available announcement details, Netflix did not provide a release date, full casting list, or production timeline for the sequel.

Technology Related

Oct 23, 8:59 PM EDT
The Apex Times

Amazon shares among AI-infrastructure selloff targets as mega-cap tech resets

A broad pullback in AI infrastructure-linked equities has hit even companies whose financial results and demand indicators were described as holding up, according to a market-focused report. Amazon was cited alongside other large technology names as investors reassess near-term spending and competitive momentum.

Amazon shares among AI-infrastructure selloff targets as mega-cap tech resets
The Apex Times
Netflix announces “Ad Vitam Eternam,” a sequel to its 2025 film “Ad Vitam” | The Apex Times